about
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.Cytogenetic Resources and Information.Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programsStress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasisPPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapySRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
P50
Q34543038-29AB95B0-2756-4B2C-B699-BB079E96CAFDQ39137467-4DFCE316-F2DC-4E9D-9A12-C9E4E77C553AQ47352505-ED90AB12-2550-46BA-AD2D-CD2ABDD2EE13Q56968690-0AC4AC73-B82F-406A-9FD3-85ABE3B65ED1Q57160043-61335259-6FBC-44AA-9C07-2F2BE41F896AQ58547326-B0F7F023-5254-4286-8C9D-7448BD7DCF3BQ60300790-D4EF5171-7E2E-4ADA-8FC7-645509C59918
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Etienne De Braekeleer
@ast
Etienne De Braekeleer
@en
Etienne De Braekeleer
@es
Etienne De Braekeleer
@nl
type
label
Etienne De Braekeleer
@ast
Etienne De Braekeleer
@en
Etienne De Braekeleer
@es
Etienne De Braekeleer
@nl
prefLabel
Etienne De Braekeleer
@ast
Etienne De Braekeleer
@en
Etienne De Braekeleer
@es
Etienne De Braekeleer
@nl
P108
P106
P31
P496
0000-0003-4659-023X